Hypereosinophilia management in patients with type 2 chronic rhinosinusitis treated with dupilumab: preliminary results
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Otorhinolaryngology
Link
https://link.springer.com/content/pdf/10.1007/s00405-022-07389-5.pdf
Reference25 articles.
1. Fokkens WJ, Lund VJ, Hopkins C et al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 58(Suppl S29):1–464. https://doi.org/10.4193/Rhin20.600
2. Yacoub MR, Trimarchi M, Cremona G et al (2015) Are atopy and eosinophilic bronchial inflammation associated with relapsing forms of chronic rhinosinusitis with nasal polyps? Clin Mol Allergy 13(1):1–6. https://doi.org/10.1186/S12948-015-0026-8/FIGURES/5
3. Trimarchi M, Indelicato P, Vinciguerra A, Bussi M (2021) Clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: the first case outside of a clinical trial. Clin Case Reports 9(3):1428–1432. https://doi.org/10.1002/ccr3.3792
4. Wollenberg A, Beck LA, Blauvelt A et al (2020) Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS). Br J Dermatol 182(5):1120–1135. https://doi.org/10.1111/BJD.18434
5. Busse WW, Maspero JF, Rabe KF et al (2018) Liberty asthma QUEST: phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy/safety in patients with uncontrolled, moderate-to-severe asthma. Adv Ther 35(5):737–748. https://doi.org/10.1007/S12325-018-0702-4
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps;European Archives of Oto-Rhino-Laryngology;2024-06-08
2. Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature review;Drugs in Context;2024-05-22
3. Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature;European Archives of Oto-Rhino-Laryngology;2024-05-19
4. The value of biomarkers in the therapy of CRSwNP with biologicals—a long-term follow-up of dupilumab therapy;European Archives of Oto-Rhino-Laryngology;2024-05-06
5. Efficacy of dupilumab in real-life settings: a STROBE study;European Archives of Oto-Rhino-Laryngology;2024-03-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3